Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenqiang Wu
Observed institution:
First Affiliated Hospital of Jiamusi University
ORCID:
0009-0006-4869-9967
Observed ORCID:
0009-0006-4869-9967
OpenAlex ID:
A5018845079
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial
2022
·
Xiaojiao Li
, Yusi Liu
, et al.
·
Antimicrobial Agents and Chemotherapy
·
16
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Capsid Assembly Modulator GST-HG141 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial
2021
·
Cuiyun Li
, Min Wu
, et al.
·
Antimicrobial Agents and Chemotherapy
·
15
Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection
2022
·
Yanbin Hu
, Fei Sun
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
11
Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: a phase 1 trial with a randomized, placebo-controlled design
2024
·
Min Wu
, Jiajia Mai
, et al.
·
Virology Journal
·
6
PDF
Berberine Inhibits Hyperlipidemia-Associated Erectile Dysfunction Through the Mediation of miR-342-3p–Related Pathway
2024
·
Wenqiang Wu
, Jinmei Li
, et al.
·
Revista Brasileira de Farmacognosia
·
1
Safety, Tolerability and Antiviral Activity of GST ‐ HG131 in Chronic Hepatitis B: A Randomized, Double‐Blind Phase IIa Study
2026
·
Yuming Guo
, Zhe Xu
, et al.
·
Liver International
PDF
Show more works
View as search
Works count:
6
Citation count:
49
H-index:
4
I10-index:
3
Year
Topic
Type